Obstructive Airway Disease Flashcards

1
Q

Airways lead to obstructive or restrictive disease

A

obstructive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

lungs = restrictive or obstructive

A

restrictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

list common obstructive airway syndromes

A

asthma
chronic bronchitis
emphysema
ACOS asthma/COPD overlap syndrome (COPD = reversibility / eosinophilia = steroid response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name the conducting zones

A

trachea - bronchi - bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

name the acinar zones

A

terminal bronchioles alveolar ducts/sacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

conducting zones are used for

A

gas transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

acinar zones are used for

A

gas exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list the large airways

A

trachea bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

list the small airways

A

bronchioles terminal bronchioles alveolar ducts/sacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

large airway size

A

> 2mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

small airway size

A

<2mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name the 3 features of the asthma triad

A

Reversible airflow obstruction
Airway inflammation
Airway hyper-responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the hallmarks of asthma remodelling

A

Basement membrane = thickening
submucosa = collaged deposition
smooth muscle = hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inflammatory Cascade in asthma

A

Inherited or acquired factors

  • genetic predisposition
  • viral, allergen, or chemical

eosinophilic inflammation

mediators/ Th2 cytokines

twitchy smooth muscle (hyperactivity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How to treat inflammatory cascade in asthma

Inherited or acquired factors

  • genetic predisposition
  • viral, allergen, or chemical
A

Avoidance of percipitant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to treat inflammatory cascade in asthma

eosinophilic inflammation

A

anti-inflammatory medication

  • coticosteroids
  • cromones
  • theophylline
17
Q

How to treat inflammatory cascade in asthma

mediators/ Th2 cytokines

A

antileukotrienes or antihistamines
monoclonal antibodies
-anti IgE/ anti-interleukin 5

18
Q

Asthma triggers

A

Allergens

  • animal disorder
  • dust mites
  • pollens
  • fungi

Others

  • exercise
  • viral infection
  • smoke
  • cold
  • chemicals
  • drugs (NSAIDs, B blockers)
19
Q

Asthma clinical setting

A

episodic symptoms + signs
diurnal variability - nocturnal/early morning
non productive cough/wheeze
triggers
associated atopy increase IgE (rhinitis, conjunctivitis, eczema)
Blood eosinophilia >4%
Responsiveness to steroids or beta agonists
Family history of asthma
Wheezing fue to turbulent airflow

20
Q

Diagnosis of asthma

A
History + examination
Diurnal variation of peak flow rate
Reduced forced expiratory ratio (FEV1/FVC <75%)
Reversibility to inh. salbutamol >15%
Provocation testing = bronchospasm
-exercise
-histamine/methacholine/mannitol
21
Q

List the 3 factors in the development of obstruction + ongoing disease progression

A

mucocilliary dysfunction
inflammation
tissue damage

22
Q

list the characteristics of COPD development

A

Exacerbations

Reduced lung function

23
Q

list the symptomsof COPD development

A

breathless

worsening quality of life

24
Q

COPD disease process

A

cigarette smoke
inflammation of lungs
COPD = normal protective +/or repair mechanisms overwhelmed/defective
Activate macrophages + airway epithelial cells
release neutrophil chemotatic factors incl. IL 8 and B4
Release proteases
Breakdown connective tissue
Mucus hyper-secretion
Proteases = counteracted by portease inhibitors (a1-antirypson, secretory leukoprotease inhibitor + tissue inhibitors of matrix metalloproteinases)

25
Characteristics of chronic bronchitis
``` chronic neutrophilic inflammation mucus hypersecretion mucociliary dysfunction altered lung dysfunction smooth muscle spasm and hypertrophy partially reversible ```
26
emphysema characteristics
alveolar destruction impaired gas exchange loss of bronchial support irreversible
27
assessment of COPD
assess symptoms assess degree of airflow limitation using spirometry assess risk of exacerbation assess comorbidites (IHD/HF)
28
high risk COPD indicataors
2 exacerbations or more within the past year | FEV1<50%
29
COPD = clinical
``` chronic symptoms - not episodic smoking non-atopic daily productive cough progressive breathlessness frequent infective exacerbations chronic bronchitis - wheezing emphysema - reduced breath sounds ```
30
chronic cascase in COPD
progressive fixed airflow obstruction impaired alveolar gas exchange resp failure (decrease PaO2 increased PaCO2) pulmonary hypertension right ventricular hypertrophy (cor pulmonale) death
31
effect of stopping smoking
arrests further decline in lung volume
32
features of asthma COPD overlap syndrome
COPD blood eosinophils >4% responds better to ICS wrt exacerbations reductions more reversible = salbutamol difficult to distinguish from asthmatic smokers = airway remodelling
33
non pharmacological COPD managemnt
smoking cessation +/- nicotine/bupropion/verecicline immunisation - influenza/ pneumococcal physical activity oxygen-domiciliary
34
pharmacological COPD managemnt
LAMA/LABA momo LABA/LAMA combo ICS/LABA combo ICS/LABA/LAMA combo
35
Asthma key features
``` non smoker allergic early/late onset intermittent symptoms non productive cough non progressive eosinophilic inflammation diurnal variability good corticosteroid response good bronchodilator response preserved FVC and TLCO normal gas exchange ```
36
COPD key features
``` smokers non allergic late onset chronic symptoms productive cough progressive decline neutrophilic inflammation (not ACOS) no diurnal variability poor corticosteroid response (not ACOS) poor bronchodilator response reduced FVC and TLCO impaired gas exchange ```